FMC’S BUSINESS MODEL IS CERTAINLY ALIVE (BUY; 39% UPSIDE)
02/10/25 -" Ostensibly, it’s difficult to make an investment case for a firm, which has eroded >30% of shareholders’ wealth over five years. For Fresenius Medical Care (BUY ; Germany) (FMC) – a market-leading ..."
Pages
68
Language
English
Published on
02/10/25
You may also be interested by these reports :
10/10/25
Key conclusions: Chinese manufacturers can produce Meta Rayban-like glasses for €25. The margin dilution impact of Meta Ray-Ban is probably lower ...
10/10/25
We have removed the long term margin dilution from Meta Ray-Ban in our model as we think the dilution won’t be as significant as we had previously ...
08/10/25
Sartorius is scheduled to report its Q3 2025 earnings on the 16th of October. Interestingly, the stock has surged c. 14% from 30 September to 7 ...
02/10/25
Ostensibly, it’s difficult to make an investment case for a firm, which has eroded >30% of shareholders’ wealth over five years. For Fresenius ...